{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:10:57Z","timestamp":1770977457837,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Merck Sharp & Dohme (Malaysia) Sdn. Bhd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15550-0","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:46:41Z","timestamp":1769755601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus (HPV) - driven head and neck squamous cell carcinoma (HNSCC) in a multi-ethnic developing country"],"prefix":"10.1186","volume":"26","author":[{"given":"Hans Prakash","family":"Sathasivam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohaizam","family":"Japar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanariah","family":"Alias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahirrudin","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasmah","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi Gopalan","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noraida","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pappathy","family":"Vairavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeline","family":"Madatang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doh Jeing","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avatar Singh","family":"Mohan Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abd Razak","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"2","key":"15550_CR1","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390.","journal-title":"Lancet Glob Health"},{"key":"15550_CR2","unstructured":"WHO Classification of Tumours Editorial Board. Head and neck tumours [beta version ahead of print], vol. 9. 5th ed. Lyon: International Agency for Research on Cancer; 2022."},{"issue":"6","key":"15550_CR3","doi-asserted-by":"publisher","first-page":"djv403","DOI":"10.1093\/jnci\/djv403","volume":"108","author":"X Castellsagu\u00e9","year":"2016","unstructured":"Castellsagu\u00e9 X, Alemany L, Quer M, Halec G, Quir\u00f3s B, Tous S, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108(6):djv403.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"15550_CR4","first-page":"122","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O\u2019Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122\u201337.","journal-title":"CA Cancer J Clin"},{"key":"15550_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13027-018-0193-6","volume":"13","author":"LF Yap","year":"2018","unstructured":"Yap LF, Lai SL, Rhodes A, Sathasivam HP, Abdullah MA, Pua KC, et al. Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection. Infect Agent Cancer. 2018;13:21.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"15550_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13027-023-00557-0","volume":"18","author":"HP Sathasivam","year":"2023","unstructured":"Sathasivam HP, Davan SP, Chua SM, Rohaizat RF, Japar R, Zakaria Z, et al. Findings from a Malaysian multicentre study on oropharyngeal squamous cell carcinoma. Infect Agent Cancer. 2023;18(1):74.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"15550_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00432-010-0886-8","volume":"137","author":"R Saini","year":"2011","unstructured":"Saini R, Tang TH, Zain RB, Cheong SC, Musa KI, Saini D, et al. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol. 2011;137(2):311\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15550_CR8","doi-asserted-by":"publisher","first-page":"524928","DOI":"10.3389\/fonc.2020.524928","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang Y, Bai W, Wang B, Wei J, Ji R, Xin Y, et al. Feasibility of immunohistochemical p16 staining in the diagnosis of human papillomavirus infection in patients with squamous cell carcinoma of the head and neck: A systematic review and Meta-Analysis. Front Oncol. 2020;10:524928.","journal-title":"Front Oncol"},{"issue":"3","key":"15550_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","volume":"24","author":"H Mehanna","year":"2023","unstructured":"Mehanna H, Taberna M, von Buchwald C, Tous S, Brooks J, Mena M, et al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol. 2023;24(3):239\u201351.","journal-title":"Lancet Oncol"},{"issue":"10","key":"15550_CR10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/annonc\/mdy313","volume":"29","author":"HP Sathasivam","year":"2018","unstructured":"Sathasivam HP, Santambrogio A, Andoniadou CL, Robinson M, Thavaraj S. Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma. Ann Oncol. 2018;29(10):2144\u20135.","journal-title":"Ann Oncol"},{"issue":"5","key":"15550_CR11","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/annonc\/mdy060","volume":"29","author":"IH Nauta","year":"2018","unstructured":"Nauta IH, Rietbergen MM, van Bokhoven AAJD, Bloemena E, Lissenberg-Witte BI, Heideman DAM, et al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Ann Oncol. 2018;29(5):1273\u20139.","journal-title":"Ann Oncol"},{"issue":"6","key":"15550_CR12","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/bjc.2013.63","volume":"108","author":"AG Schache","year":"2013","unstructured":"Schache AG, Liloglou T, Risk JM, Jones TM, Ma XJ, Wang H, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer. 2013;108(6):1332\u20139.","journal-title":"Br J Cancer"},{"issue":"12","key":"15550_CR13","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/modpathol.2015.113","volume":"28","author":"H Mirghani","year":"2015","unstructured":"Mirghani H, Casiraghi O, Amen F, He M, Ma X-J, Saulnier P, et al. Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol. 2015;28(12):1518\u201327.","journal-title":"Mod Pathol"},{"issue":"9","key":"15550_CR14","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/cncr.25033","volume":"116","author":"AD Singhi","year":"2010","unstructured":"Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116(9):2166\u201373.","journal-title":"Cancer"},{"key":"15550_CR15","volume-title":"Report 2012\u20132016","year":"2019","unstructured":"Malaysian National Cancer Registry. In: Putrajaya, editor. Report 2012\u20132016. Malaysia: National Cancer Institute, Ministry of Health, Malaysia; 2019."},{"key":"15550_CR16","volume-title":"Report 2007\u20132011","year":"2016","unstructured":"Malaysian National Cancer Registry. In: Putrajaya, editor. Report 2007\u20132011. Malaysia: National Cancer Institute, Ministry of Health, Malaysia; 2016."},{"key":"15550_CR17","doi-asserted-by":"publisher","first-page":"833048","DOI":"10.3389\/fsurg.2021.833048","volume":"8","author":"HW Jun","year":"2021","unstructured":"Jun HW, Ji YB, Song CM, Myung JK, Park HJ, Tae K. Positive rate of human papillomavirus and its trend in head and neck cancer in South Korea. Front Surg. 2021;8:833048.","journal-title":"Front Surg"},{"issue":"9","key":"15550_CR18","doi-asserted-by":"publisher","first-page":"e0221045","DOI":"10.1371\/journal.pone.0221045","volume":"14","author":"G Ni","year":"2019","unstructured":"Ni G, Huang K, Luan Y, Cao Z, Chen S, Ma B, et al. Human papillomavirus infection among head and neck squamous cell carcinomas in Southern China. PLoS ONE. 2019;14(9):e0221045.","journal-title":"PLoS ONE"},{"issue":"8","key":"15550_CR19","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1111\/cas.16230","volume":"115","author":"KI Nibu","year":"2024","unstructured":"Nibu KI, Oridate N, Saito Y, Roset M, Fores Maresma M, Cuadras D, et al. Human papillomavirus-driven head and neck cancers in Japan during 2008\u20132009 and 2018\u20132019: the BROADEN study. Cancer Sci. 2024;115(8):2808\u201318.","journal-title":"Cancer Sci"},{"issue":"5","key":"15550_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hed.22015","volume":"35","author":"H Mehanna","year":"2013","unstructured":"Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2013systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747\u201355.","journal-title":"Head Neck"},{"key":"15550_CR21","doi-asserted-by":"crossref","unstructured":"Carlander AF, Jakobsen KK, Bendtsen SK, Garset-Zamani M, Lynggaard CD, Jensen JS, et al. A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide. Viruses. 2021;13(7):1326.","DOI":"10.3390\/v13071326"},{"issue":"12","key":"15550_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","volume":"15","author":"C Ndiaye","year":"2014","unstructured":"Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsague X, Laporte L, et al. HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319\u201331.","journal-title":"Lancet Oncol"},{"issue":"5","key":"15550_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/cncr.31841","volume":"125","author":"F Faraji","year":"2019","unstructured":"Faraji F, Rettig EM, Tsai HL, El Asmar M, Fung N, et al. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status. Cancer. 2019;125(5):761\u20139.","journal-title":"Cancer"},{"issue":"22","key":"15550_CR24","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","volume":"76","author":"AG Schache","year":"2016","unstructured":"Schache AG, Powell NG, Cuschieri KS, Robinson M, Leary S, Mehanna H, et al. HPV-Related oropharynx cancer in the united kingdom: an evolution in the Understanding of disease etiology. Cancer Res. 2016;76(22):6598\u2013606.","journal-title":"Cancer Res"},{"issue":"4","key":"15550_CR25","doi-asserted-by":"publisher","first-page":"E278","DOI":"10.1111\/ans.13759","volume":"88","author":"P Ou","year":"2018","unstructured":"Ou P, Gear K, Rahnama F, Thomas S, Nagappan R, Kee D, et al. Human papillomavirus and oropharyngeal squamous cell carcinoma: a new Zealand cohort study. ANZ J Surg. 2018;88(4):E278\u201383.","journal-title":"ANZ J Surg"},{"key":"15550_CR26","doi-asserted-by":"publisher","first-page":"103116","DOI":"10.1016\/j.critrevonc.2020.103116","volume":"156","author":"B Mariz","year":"2020","unstructured":"Mariz B, Kowalski LP, William WN Jr., de Castro G Jr., Chaves ALF, Santos M, et al. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;156:103116.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"15550_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamaoncol.2016.3067","volume":"3","author":"G D\u2019Souza","year":"2017","unstructured":"D\u2019Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, et al. Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method. JAMA Oncol. 2017;3(2):169\u201377.","journal-title":"JAMA Oncol"},{"key":"15550_CR28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3389\/fonc.2020.01751","volume":"10","author":"JG Augustin","year":"2020","unstructured":"Augustin JG, Lepine C, Morini A, Brunet A, Veyer D, Brochard C, et al. HPV detection in head and neck squamous cell carcinomas: what is the issue? Front Oncol. 2020;10:1751.","journal-title":"Front Oncol"},{"issue":"3","key":"15550_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cncr.31031","volume":"124","author":"WB Huang","year":"2018","unstructured":"Huang WB, Chan JYW, Liu DL. Human papillomavirus and world health organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124(3):530\u20136.","journal-title":"Cancer"},{"issue":"5","key":"15550_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","volume":"142","author":"JS Lewis Jr","year":"2018","unstructured":"Lewis JS Jr., Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists. Arch Pathol Lab Med. 2018;142(5):559\u201397.","journal-title":"Arch Pathol Lab Med"},{"key":"15550_CR31","doi-asserted-by":"crossref","unstructured":"Koksal MO, Yalcin BK, Keskin F, Ciftci S, Yagci I, Hascicek SO, et al. Genotype distribution and prevalence of human papillomavirus in head and neck cancer samples from Istanbul, Turkey. Pathogens. 2021;10(12):1533.","DOI":"10.3390\/pathogens10121533"},{"issue":"12","key":"15550_CR32","doi-asserted-by":"publisher","first-page":"e0278477","DOI":"10.1371\/journal.pone.0278477","volume":"17","author":"SP Khoo","year":"2022","unstructured":"Khoo SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, Gravitt P, Ng CW, et al. Changes in genital human papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program. PLoS ONE. 2022;17(12):e0278477.","journal-title":"PLoS ONE"},{"issue":"9","key":"15550_CR33","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.31557\/APJCP.2021.22.9.2969","volume":"22","author":"F Rahmat","year":"2021","unstructured":"Rahmat F, Kuan JY, Hajiman Z, Mohamed Shakrin NNS, Che Roos NA, Mustapa M, et al. Human papillomavirus (HPV) prevalence and type distribution in urban areas of Malaysia. Asian Pac J Cancer Prev. 2021;22(9):2969\u201376.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"15550_CR34","first-page":"2807","volume":"19","author":"NE Sainei","year":"2018","unstructured":"Sainei NE, Kumar VS, Chin YS, Salih FAM. High prevalence of human papillomavirus types 56 and 70 identified in the native populations of Sabah, Malaysia. Asian Pac J Cancer Prev. 2018;19(10):2807\u201313.","journal-title":"Asian Pac J Cancer Prev"},{"key":"15550_CR35","doi-asserted-by":"crossref","unstructured":"Tan SC, Ismail MP, Duski DR, Othman NH, Ankathil R. Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate. Biosci Rep. 2018;38(2):BSR20171268.","DOI":"10.1042\/BSR20171268"},{"issue":"1","key":"15550_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2012.03.033","volume":"323","author":"M Hoffmann","year":"2012","unstructured":"Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, et al. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Cancer Lett. 2012;323(1):88\u201396.","journal-title":"Cancer Lett"},{"key":"15550_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.oraloncology.2018.01.010","volume":"78","author":"M Mena","year":"2018","unstructured":"Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, et al. Double positivity for HPV-DNA\/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral Oncol. 2018;78:137\u201344.","journal-title":"Oral Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15550-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:15:51Z","timestamp":1770974151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15550-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15550"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15550-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in compliance with relevant laws and institutional guidelines and have been approved by the Malaysian Ministry of Health Medical Research and Ethics Committee (NMRR-21-629-59503). The need for informed consent was waived by the Malaysian Ministry of Health Medical Research and Ethics Committee due to the retrospective study design. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HPS received funding for this study from the Investigator-Initiated Studies Program of Merck Sharp & Dohme (Malaysia) Sdn. Bhd. Aside from that, the authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}